Neuralace

PRESS & MEDIA

Track Our Latest News &
Breakthroughs in Neuromodulation

Track Our Latest News & Breakthroughs in Neuromodulation

Keep up with news, press, and media buzz about Axon Therapy® mPNS.
New Patents Protect innovative Axon™ Therapy, a Non-Invasive
New Patents Protect innovative Axon™ Therapy, a Non-Invasive and Non-Pharmacological Solution for Treating Neuropathic Pain, as NeuraLace's Clinical Strategy Advances Focusing on Neuropathic Pain Related to Surgery, Trauma and Diabetic Neuropathy
Highly Accomplished Visionary with Proven Track Record of
Highly Accomplished Visionary with Proven Track Record of Healthcare Industry Leadership Highlighted by Game Changing Technologies and Investor Success
Axon Therapy Offers Maximum Versatility by Delivering NeuraLace's
Axon Therapy Offers Maximum Versatility by Delivering NeuraLace's Proprietary Treatment Non-Invasively to Peripheral Nerves
Study to Evaluate the Efficacy and Economic Benefit
Study to Evaluate the Efficacy and Economic Benefit of Axon Therapy® Designed to Relieve Pain and Improve Quality of Life Compared with Conventional Medical Management.
Contact us for Press & Media Inquiries

Keith Warner

Chief Executive Officer

Proactive and engaging leader with expertise in advanced strategy development and implementation driving outstanding corporate growth. Over 25 years of senior level business acumen gained through key executive positions with leading large cap to venture stage startups within the life sciences and medical technology sectors. Experience in organization-building geared to achieve near and long term milestones both in domestic and international settings. Ability to deliver significant transformation and growth in financial performance, product development, investor fundraising, capital restructuring, P&L management, and strategic planning.